Mendus signs agreement with Olivia Newton-John Cancer Research Institute to expand clinical development of vididencel in AML

What we doOur approachPipelineTechnologyPublicationsPatient Stories
About usExecutive ManagementBoard of DirectorsCareers
News & eventsPress releasesEventsInterviews
Investors

Back
Mendus signs agreement with Olivia Newton-John Cancer Research Institute to expand clinical development of vididencel in AML
 8:00:00 AM

Keep reading
Notice of Annual General Meeting in Mendus AB (publ)Read